TEL AVIV SOURASKY MEDICAL CENTER
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Private
- Established
- 1961-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.tasmc.org.il
Clinical Trials
539
Active:4
Completed:84
Trial Phases
6 Phases
Early Phase 1:5
Phase 1:16
Phase 2:42
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (374 trials with phase data)• Click on a phase to view related trials
Not Applicable
248 (66.3%)Phase 2
42 (11.2%)Phase 3
32 (8.6%)Phase 4
31 (8.3%)Phase 1
16 (4.3%)Early Phase 1
5 (1.3%)Plant vs Animal-based Protein Sources as an Anabolic and Metabolic-protective Options for SO in Older Adults
Not Applicable
Not yet recruiting
- Conditions
- Sarcopenic ObesityObesity and Obesity-related Medical ConditionsObesity (Body Mass Index >30 kg/m2)SarcopeniaMuscle LossAging
- First Posted Date
- 2025-06-22
- Last Posted Date
- 2025-06-22
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 180
- Registration Number
- NCT07030738
- Locations
- 🇮🇱
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Early Beta Blocker Administration in STEMI Patients With SCAI B Status
Not Applicable
Recruiting
- Conditions
- ST Segment Elevation Myocardial Infarction (STEMI)Cardiogenic Shock Post Myocardial Infarction
- Interventions
- Drug: Plcacebo
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT06967194
- Locations
- 🇮🇱
Tel Aviv Sourasky Medical center, Tel Aviv, Israel
Evaluation of Fentanyl Transdermal Patch Absorption in Hemodynamically Unstable ICU Patients.
- First Posted Date
- 2025-05-13
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT06966869
- Locations
- 🇮🇱
Tel Aviv Medical Center, Tel Aviv, Israel
Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
Recruiting
- Conditions
- MyelomaLymphomaCLLMyelodysplastic SyndromeLeukemia Acute Myeloid - AML
- First Posted Date
- 2025-04-25
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 250
- Registration Number
- NCT06944119
- Locations
- 🇮🇱
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Emotional Release After Trigger Point Needling to Treat Myofascial Pain of the Head and Neck - Prospective Study
- Conditions
- Temporomandibular Disorders (TMD)Temporomandibular Dysfunction (TMD)Temporomandibular Joint and Muscle Disorder
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT06912438
- Locations
- 🇮🇱
Oral Medicine Unite, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
- Prev
- 1
- 2
- 3
- 4
- 5
- 108
- Next
News
No news found